PP18

PP18 is a novel OXM-based dual GLP-1 and glucagon receptor agonist with EC50 values of 0.487 nM target hGLP-1R and 0.188 nM target hGcgR[1].

Product Specifications

UNSPSC

12352209

Target

GLP Receptor

Type

Peptides

Related Pathways

GPCR/G Protein

Applications

Metabolism-protein/nucleotide metabolism

Field of Research

Metabolic Disease

Assay Protocol

https://www.medchemexpress.com/pp18.html

Solubility

10 mM in DMSO

Smiles

O=C([C@@H](N)C)N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(NCC(NCC(N[C@H](C(NCC(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(O)=O)C)=O)[C@H](CC)C)=O)CC(N)=O)=O)CC(N)=O)=O)CCCNC(N)=N)=O)CC(N)=O)=O)CCCNC(N)=N)=O)C)=O)[C@@H](C)O)=O)CC(N)=O)=O)CCSC)=O)CC(C)C)=O)CC1=CNC2=CC=CC=C12)=O)CCC(N)=O)=O)C(C)C)=O)CC3=CC=CC=C3)=O)CC(O)=O)=O)CCC(N)=O)=O)C)=O)CCCNC(N)=N)=O)CCCNC(N)=N)=O)CO)=O)CC(O)=O)=O)CC(C)C)=O)CC4=CC=C(O)C=C4)=O)CCCCNC(COCCOCCNC(COCCOCCNC(CC[C@@H](C(O)=O)NC(CCCCCCCCCCCCCCCCC(O)=O)=O)=O)=O)=O)=O)CO)=O)CC5=CC=C(O)C=C5)=O)CC(O)=O)=O)CO)=O)[C@@H](C)O)=O)CC6=CC=CC=C6)=O)[C@@H](C)O)=O)=O)CCC(N)=O)=O)=O)=O)[C@H](CC)C)=O)C)=O)C(C)C)=O)C)=O)CC(N)=O)=O)CC(O)=O)=O)C(C)C)=O)CC(C)C)=O)CCC(O)=O)=O)C)=O)CS

Molecular Formula

C269H426N74O88S2

Molecular Weight

6168.83

References & Citations

[1]Lei Zhao, et al. Design, screening and biological evaluation of novel fatty acid chain-modified oxyntomodulin-based derivatives with prolonged glucose-lowering ability and potent anti-obesity effects. Org Biomol Chem. 2019, 17, 33.